The Use of Hexacapron in Upper Gastrointestinal Bleeding
Status:
Unknown status
Trial end date:
2015-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to conduct a randomized control trial, double-blind study to
compare Hexacapron with standard of care treatment to standard of care alone to evaluate the
efficacy of adding effect of Hexacapron to standard therapy by decreasing the episodes of
rebleeding and mortality in patient with upper gastrointestinal bleeding.